| Year |
Citation |
Score |
| 2024 |
Nuechterlein N, Shelbourn A, Szulzewsky F, Arora S, Casad M, Pattwell S, Merino-Galan L, Sulman E, Arowa S, Alvinez N, Jung M, Brown D, Tang K, Jackson S, Stoica S, et al. Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype. Genes & Development. PMID 38589034 DOI: 10.1101/gad.351350.123 |
0.313 |
|
| 2022 |
Modrek AS, Eskilsson E, Ezhilarasan R, Wang Q, Goodman LD, Ding Y, Zhang ZY, Bhat KPL, Le TT, Barthel FP, Tang M, Yang J, Long L, Gumin J, Lang FF, ... ... Sulman EP, et al. PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells. Frontiers in Oncology. 12: 941657. PMID 36059614 DOI: 10.3389/fonc.2022.941657 |
0.738 |
|
| 2022 |
Stitzlein L, Gangadharan A, Grasse L, Espejo A, Singh M, Lu Y, Ezhilarasan R, Gumin J, Sulman E, Lang F, Chandra J. Evaluation of in vitro and in vivo efficacy of pharmacological lysine-specific demethylase 1 (LSD1) inhibitors in glioblastoma stem cell (GSC) models. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 35554689 DOI: 10.1096/fasebj.2022.36.S1.0R249 |
0.335 |
|
| 2021 |
Huang T, Yang Y, Song X, Wan X, Wu B, Sastry N, Horbinski CM, Zeng C, Tiek D, Goenka A, Liu F, Brennan CW, Kessler JA, Stupp R, Nakano I, ... Sulman EP, et al. PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells. Molecular Cell. PMID 33539787 DOI: 10.1016/j.molcel.2021.01.015 |
0.319 |
|
| 2020 |
Cui X, Ma C, Vasudevaraja V, Serrano J, Tong J, Peng Y, Delorenzo M, Shen G, Frenster J, Morales RT, Qian W, Tsirigos A, Chi AS, Jain R, Kurz SC, ... Sulman EP, et al. Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy. Elife. 9. PMID 32909947 DOI: 10.7554/Elife.52253 |
0.335 |
|
| 2020 |
Sa JK, Chang N, Lee HW, Cho HJ, Ceccarelli M, Cerulo L, Yin J, Kim SS, Caruso FP, Lee M, Kim D, Oh YT, Lee Y, Her NG, Min B, ... ... Sulman EP, et al. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma. Genome Biology. 21: 216. PMID 32847614 DOI: 10.1186/S13059-020-02140-X |
0.396 |
|
| 2020 |
Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, McAvoy S, McAleer MF, Lin SH, Li J, Ghia AJ, Zhu C, Sulman EP, de Groot JF, Heimberger AB, et al. Proton Therapy Reduces the Likelihood of High-Grade Radiation-Induced Lymphopenia in Glioblastoma Patients: Phase II Randomized Study of Protons vs. Photons. Neuro-Oncology. PMID 32750703 DOI: 10.1093/Neuonc/Noaa182 |
0.318 |
|
| 2020 |
Vougiouklakis T, Aung PP, Vasudevaraja V, Prieto VG, Torres-Cabala CA, Sulman EP, Snuderl M, Jour G. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors. Scientific Reports. 10: 12996. PMID 32747660 DOI: 10.1038/S41598-020-69787-1 |
0.389 |
|
| 2020 |
Chen Z, Herting CJ, Ross JL, Gabanic B, Puigdelloses Vallcorba M, Szulzewsky F, Wojciechowicz ML, Cimino PJ, Ezhilarasan R, Sulman EP, Ying M, Ma'ayan A, Read RD, Hambardzumyan D. Genetic driver mutations introduced in identical cell-of-origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade. Glia. PMID 32639068 DOI: 10.1002/Glia.23883 |
0.378 |
|
| 2020 |
Liu EK, Yu S, Sulman EP, Kurz SC. Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma. Journal of Neuro-Oncology. PMID 32617722 DOI: 10.1007/S11060-020-03572-Y |
0.319 |
|
| 2020 |
Ott M, Kassab C, Marisetty A, Hashimoto Y, Wei J, Zamler DB, Leu JS, Tomaszowski KH, Sabbagh A, Fang D, Gupta P, Priebe W, Zielinski R, Burks JK, Long JP, ... ... Sulman EP, et al. Radiation with STAT3 blockade triggers dendritic cell-T cell interactions in the glioma microenvironment and therapeutic efficacy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32605912 DOI: 10.1158/1078-0432.Ccr-19-4092 |
0.398 |
|
| 2020 |
Liu EK, Silverman JS, Sulman EP. Stereotactic Radiation for Treating Primary and Metastatic Neoplasms of the Spinal Cord. Frontiers in Oncology. 10: 907. PMID 32582555 DOI: 10.3389/Fonc.2020.00907 |
0.317 |
|
| 2020 |
Liu EK, Sulman EP, Wen PY, Kurz SC. Novel Therapies for Glioblastoma. Current Neurology and Neuroscience Reports. 20: 19. PMID 32445058 DOI: 10.1007/S11910-020-01042-6 |
0.369 |
|
| 2020 |
Buxton MB, Alexander BM, Berry DA, Cavenee WK, Colman H, Groot JFD, Ellingson BM, Gordon GB, Khasraw M, Lassman AB, Li W, Lim M, Mellinghoff IK, Perry JR, Sulman EP, et al. GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps2579 |
0.365 |
|
| 2020 |
Liu E, Oh C, Sulman EP. Relative and absolute risk of second primary neoplasms of the central nervous system. Journal of Clinical Oncology. 38: 1593-1593. DOI: 10.1200/Jco.2020.38.15_Suppl.1593 |
0.305 |
|
| 2020 |
Rahal O, Yang J, Li L, Larson R, Laere SV, Ueno N, Sulman E, Woodward W. Abstract P6-06-08: Transcriptome analysis of patient derived xenograft mouse models of inflammatory breast cancer to gain insights into the contribution of tumor microenvironment Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P6-06-08 |
0.356 |
|
| 2019 |
Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu WJ, Prieto VG, et al. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. Cancers. 11. PMID 31888295 DOI: 10.3390/Cancers11122031 |
0.347 |
|
| 2019 |
Wu S, Gao F, Zheng S, Zhang C, Martinez-Ledesma E, Ezhilarasan R, Ding J, Li X, Feng N, Multani A, Sulman EP, Verhaak RG, de Groot JF, Heffernan TP, Yung WKA, et al. EGFR amplification induces increased DNA damage response and renders selective sensitivity to Talazoparib (PARP inhibitor) in glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31852834 DOI: 10.1158/1078-0432.Ccr-19-2549 |
0.316 |
|
| 2019 |
Vaubel RA, Tian S, Remonde D, Schroeder MA, Mladek AC, Kitange GJ, Caron A, Kollmeyer TM, Grove R, Peng S, Carlson BL, Ma DJ, Sarkar G, Evers L, Decker PA, ... ... Sulman EP, et al. Genomic and phenotypic characterization of a broad panel of patient derived xenografts reflects the diversity of glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31852831 DOI: 10.1158/1078-0432.Ccr-19-0909 |
0.392 |
|
| 2019 |
Ma J, Benitez JA, Li J, Miki S, Ponte de Albuquerque C, Galatro T, Orellana L, Zanca C, Reed R, Boyer A, Koga T, Varki NM, Fenton TR, Nagahashi Marie SK, Lindahl E, ... ... Sulman EP, et al. Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair. Cancer Cell. 36: 690-691. PMID 31821785 DOI: 10.1016/J.Ccell.2019.11.008 |
0.309 |
|
| 2019 |
Bledea R, Vasudevaraja V, Patel S, Stafford J, Serrano J, Esposito G, Tredwin LM, Goodman N, Kloetgen A, Golfinos JG, Zagzag D, Weigelt B, Iafrate AJ, Sulman EP, Chi AS, et al. Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers. Scientific Reports. 9: 16830. PMID 31727977 DOI: 10.1038/S41598-019-53262-7 |
0.316 |
|
| 2019 |
Yang Y, Dodbele S, Park T, Glass R, Bhat K, Sulman EP, Zhang Y, Abounader R. MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway. Journal of Neuro-Oncology. PMID 31482267 DOI: 10.1007/S11060-019-03275-Z |
0.306 |
|
| 2019 |
Gates EDH, Yang J, Fukumura K, Lin JS, Weinberg JS, Prabhu SS, Long L, Fuentes D, Sulman EP, Huse JT, Schellingerhout D. Spatial Distance Correlates With Genetic Distance in Diffuse Glioma. Frontiers in Oncology. 9: 676. PMID 31417865 DOI: 10.3389/Fonc.2019.00676 |
0.37 |
|
| 2019 |
Burgenske DM, Yang J, Decker PA, Kollmeyer TM, Kosel ML, Mladek AC, Caron AA, Vaubel RA, Gupta SK, Kitange GJ, Sicotte H, Youland RS, Remonde D, Voss JS, Fritcher EGB, ... ... Sulman EP, et al. Molecular Profiling of Long-Term IDH-wildtype Glioblastoma Survivors. Neuro-Oncology. PMID 31346613 DOI: 10.1093/Neuonc/Noz129 |
0.323 |
|
| 2019 |
Farooqi A, Yang J, Sharin V, Ezhilarasan R, Danussi C, Alvarez C, Dharmaiah S, Irvin D, Huse J, Sulman EP. Identification of patient-derived glioblastoma stem cell (GSC) lines with the alternative lengthening of telomeres phenotype. Acta Neuropathologica Communications. 7: 76. PMID 31097032 DOI: 10.1186/S40478-019-0732-4 |
0.345 |
|
| 2019 |
Ma J, Benitez JA, Li J, Miki S, Ponte de Albuquerque C, Galatro T, Orellana L, Zanca C, Reed R, Boyer A, Koga T, Varki NM, Fenton TR, Nagahashi Marie SK, Lindahl E, ... ... Sulman EP, et al. Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair. Cancer Cell. PMID 30827889 DOI: 10.1016/J.Ccell.2019.01.020 |
0.385 |
|
| 2019 |
Wang Y, Yang J, Wild AT, Wu WH, Shah R, Danussi C, Riggins GJ, Kannan K, Sulman EP, Chan TA, Huse JT. G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma. Nature Communications. 10: 943. PMID 30808951 DOI: 10.1038/S41467-019-08905-8 |
0.327 |
|
| 2019 |
Minata M, Audia A, Shi J, Lu S, Bernstock J, Pavlyukov MS, Das A, Kim SH, Shin YJ, Lee Y, Koo H, Snigdha K, Waghmare I, Guo X, Mohyeldin A, ... ... Sulman EP, et al. Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation. Cell Reports. 26: 1893-1905.e7. PMID 30759398 DOI: 10.1016/J.Celrep.2019.01.076 |
0.408 |
|
| 2019 |
Chumakova AP, Hitomi M, Sulman EP, Lathia JD. High-throughput automated single-cell imaging analysis reveals dynamics of glioblastoma stem cell population during state transition. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 30729665 DOI: 10.1002/Cyto.A.23728 |
0.376 |
|
| 2019 |
Yeboa DN, Yu JB, Liao E, Huse J, Penas-Prado M, Kann BH, Sulman E, Grosshans D, Contessa J. Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas. Clinical and Translational Radiation Oncology. 15: 46-52. PMID 30656222 DOI: 10.1016/J.Ctro.2018.12.003 |
0.366 |
|
| 2019 |
Huang T, Wan X, Alvarez AA, James CD, Song X, Yang Y, Sastry N, Nakano I, Sulman EP, Hu B, Cheng SY. MIR93 (microRNA -93) Regulates Tumorigenicity and Therapy Response of Glioblastoma by Targeting Autophagy. Autophagy. PMID 30654687 DOI: 10.1080/15548627.2019.1569947 |
0.341 |
|
| 2019 |
Yung WKA, Wu S, Gao F, Zheng S, Ding J, Zhang C, Li X, Ezhilarasan R, Feng N, De Groot JF, Sulman EP, Heffernan T, Koul D. EGFR amplification predicted selective sensitivity to PARP inhibitors with high PARP-DNA trapping potential in human GBM. Journal of Clinical Oncology. 37: 2047-2047. DOI: 10.1200/Jco.2019.37.15_Suppl.2047 |
0.333 |
|
| 2019 |
Park SY, Piao Y, Martinez-Ledesma E, Dong J, Khan S, Mittal S, Zhang Z, Sulman EP, Balasubramaniyan V, Groot JFd. Abstract 4678: Targeting MEK in EGFR amplified glioma stem like cells induces differentiation Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4678 |
0.344 |
|
| 2019 |
Lee W, Gomez D, Zhang J, Reuben A, Jalali A, Roh W, Wu CC, Lu W, Chow C, Fujimoto J, Antonoff M, Moran C, Sulman E, Rao G, Swisher S, et al. Abstract 2741: Comprehensive molecular profiling of primary tumors and paired distant metastases in non-small cell lung cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2741 |
0.353 |
|
| 2019 |
Zhang Z, Ding Y, Ezhilarasan R, Yang J, Long L, Bronk L, Wang Q, Sulman EP. Abstract 1917: High-throughput evaluation of treatment response in patient-derived glioma stem cell models Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1917 |
0.357 |
|
| 2019 |
Zhang Z, Ezhilarasan R, Ding Y, Wang Q, Yang J, Long L, Verhaak RG, Sulman EP. Abstract 4698: Development of a CRISPR-Cas9D10Atargetable, high-complexity, single-cell barcoding approach for capture of treatment resistant subclones from heterogeneous cancers Cancer Research. 79: 4698-4698. DOI: 10.1158/1538-7445.Am2019-4698 |
0.374 |
|
| 2019 |
Yang J, Wang Q, Ezhilarasan R, Long L, Wiestler B, Wick W, Miao Y, Sulman E. Abstract 4238: DNA-methylation based epigenetic signatures predict and deconvolute somatic genomic alterations in gliomas Cancer Research. 79: 4238-4238. DOI: 10.1158/1538-7445.Am2019-4238 |
0.406 |
|
| 2019 |
Fukumura K, Mao X, Song X, Fischer GM, Yang J, Sulman EP, Davies MA, Zhang J, Huse JT. Abstract 3406: Comprehensive genomic analysis of brain metastases from multiple cancer types Cancer Research. 79: 3406-3406. DOI: 10.1158/1538-7445.Am2019-3406 |
0.37 |
|
| 2019 |
McGovern S, Luo D, Johnson M, Nguyen K, Li J, McAleer M, Yeboa D, Grosshans D, Ghia A, Chung C, Thall P, Sulman E, Brown P, Mahajan A. RTHP-23. PROSPECTIVE TRIAL OF CONVENTIONALLY FRACTIONATED DOSE CONSTRAINTS FOR RE-IRRADIATION OF PRIMARY BRAIN TUMORS Neuro-Oncology. 21: vi214-vi214. DOI: 10.1093/Neuonc/Noz175.894 |
0.357 |
|
| 2019 |
Al Feghali K, Randall J, Wefel J, Guha-Thakurta N, Grosshans D, Dibaj S, McAvoy S, Li J, McGovern S, McAleer M, Ghia A, Paulino A, Sulman E, Penas-Prado M, Wang J, et al. NIMG-03. PROSPECTIVE PHASE II RANDOMIZED TRIAL COMPARING PROTON THERAPY VS. PHOTON IMRT FOR GBM: SECONDARY ANALYSIS COMPARISON OF PROGRESSION FREE SURVIVAL BETWEEN RANO VS. CLINICAL AND RADIOLOGICAL ASSESSMENT Neuro-Oncology. 21: vi161-vi162. DOI: 10.1093/Neuonc/Noz175.675 |
0.353 |
|
| 2019 |
Balasubramaniyan V, Park S, Piao Y, Martínez E, Dong J, Mittal S, Khan S, Zhang Z, Sulman E, DeGroot J. Ddis-32. Mek Inhibitors Induces Neuronal Differentiation In Egfr Amplified Glioma Stem Like Cells Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.283 |
0.315 |
|
| 2019 |
Arrillaga-Romany I, Kurz S, Sumrall A, Butowski N, Harrison R, DeGroot J, Chi A, Sulman E, Shonka N, Umemura Y, Odia Y, Mehta M, Iwamoto F, Leia Nghiemphu P, Cloughesy T, et al. ACTR-34. SINGLE AGENT ONC201 IN PREVIOUSLY-TREATED, PROGRESSIVE ADULT H3 K27M-MUTANT GLIOMA Neuro-Oncology. 21: vi20-vi21. DOI: 10.1093/Neuonc/Noz175.077 |
0.324 |
|
| 2018 |
Olar A, Tran D, Mehta VP, Reinhardt A, Manekia JH, Garnovskaya M, Ellezam B, Luthra R, Sulman EP, Mohila CA, Campbell GA, Powell SZ, Fuller GN, Aldape KD, Adesina AM. ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features. Clinical Neuropathology. PMID 30499772 DOI: 10.5414/Np301105 |
0.323 |
|
| 2018 |
Spino M, Kurz SC, Chiriboga L, Serrano J, Zeck B, Sen N, Patel S, Shen G, Vasudevaraja V, Tsirigos A, Suryadevara CM, Frenster JD, Tateishi K, Wakimoto H, Jain R, ... ... Sulman EP, et al. Cell surface Notch ligand DLL3 is a therapeutic target in isocitrate dehydrogenase mutant glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30397180 DOI: 10.1158/1078-0432.Ccr-18-2312 |
0.335 |
|
| 2018 |
Jour G, Vasudevaraja V, Prieto VG, Snuderl M, Torres-Cabala CA, Al-Rohil R, Sulman EP, Ballester LY, Aung PP. BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 30310175 DOI: 10.1038/S41379-018-0146-Z |
0.354 |
|
| 2018 |
Yuan AL, Ricks CB, Bohm AK, Lun X, Maxwell L, Safdar S, Bukhari S, Gerber A, Sayeed W, Bering EA, Pedersen H, Chan JA, Shen Y, Marra M, Kaplan DR, ... ... Sulman EP, et al. ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts. Plos One. 13: e0202860. PMID 30153289 DOI: 10.1371/Journal.Pone.0202860 |
0.698 |
|
| 2018 |
Latha K, Yan J, Yang Y, Gressot LV, Kong LY, Manyam G, Ezhilarasan R, Wang Q, Sulman EP, Eric Davis R, Huang S, Fuller GN, Rao A, Heimberger AB, Li S, et al. The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma. Journal of the National Cancer Institute. PMID 29947810 DOI: 10.1093/Jnci/Djy107 |
0.405 |
|
| 2018 |
Pietanza MC, Waqar SN, Krug LM, Dowlati A, Hann CL, Chiappori A, Owonikoko TK, Woo KM, Cardnell RJ, Fujimoto J, Long L, Diao L, Wang J, Bensman Y, Hurtado B, ... ... Sulman EP, et al. Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018777672. PMID 29906251 DOI: 10.1200/Jco.2018.77.7672 |
0.351 |
|
| 2018 |
Olar A, Goodman LD, Wani KM, Boehling NS, Sharma DS, Mody RR, Gumin J, Claus EB, Lang FF, Cloughesy TF, Lai A, Aldape KD, DeMonte F, Sulman EP. A gene expression signature predicts recurrence-free survival in meningioma. Oncotarget. 9: 16087-16098. PMID 29662628 DOI: 10.18632/Oncotarget.24498 |
0.719 |
|
| 2018 |
Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM, Hossain A, Akers JC, Maiti SN, Yamashita S, Shimizu Y, ... ... Sulman EP, et al. Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes. Oncoimmunology. 7: e1412909. PMID 29632728 DOI: 10.1080/2162402X.2017.1412909 |
0.316 |
|
| 2018 |
Dong J, Park SY, Nguyen N, Ezhilarasan R, Martinez-Ledesma E, Wu S, Henry V, Piao Y, Tiao N, Brunell D, Stephan C, Verhaak R, Sulman E, Balasubramaniyan V, de Groot JF. The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. Oncotarget. 9: 10497-10509. PMID 29535822 DOI: 10.18632/Oncotarget.24041 |
0.397 |
|
| 2018 |
Danussi C, Bose P, Parthasarathy PT, Silberman PC, Van Arnam JS, Vitucci M, Tang OY, Heguy A, Wang Y, Chan TA, Riggins GJ, Sulman EP, Lang F, Creighton CJ, Deneen B, et al. Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling. Nature Communications. 9: 1057. PMID 29535300 DOI: 10.1038/S41467-018-03476-6 |
0.389 |
|
| 2018 |
Aldape K, Amin SB, Ashley DM, Barnholtz-Sloan JS, Bates AJ, Beroukhim R, Bock C, Brat DJ, Claus EB, Costello JF, de Groot JF, Finocchiaro G, French PJ, Gan HK, Griffith B, ... ... Sulman EP, et al. Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. Neuro-Oncology. PMID 29432615 DOI: 10.1093/Neuonc/Noy020 |
0.378 |
|
| 2018 |
Luedi MM, Singh SK, Mosley JC, Hassan ISA, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR, Zinn PO. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma. Journal of Neurosurgery. 1-10. PMID 29328002 DOI: 10.3171/2017.7.Jns17668 |
0.452 |
|
| 2018 |
Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, ... ... Sulman EP, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 33: 152. PMID 29316430 DOI: 10.1016/J.Ccell.2017.12.012 |
0.393 |
|
| 2018 |
Wefel JS, Deshmukh S, Brown PD, Grosshans DR, Sulman EP, Cerhan JH, Mehta MP, Khuntia D, Shi W, Mishra MV, Suh JH, Laack NN, Chen Y, Curtis A, Laba J, et al. Impact of apolipoprotein E (APOE) genotype on neurocognitive function (NCF) in patients with brain metastasis (BM): An analysis of NRG Oncology’s RTOG 0614. Journal of Clinical Oncology. 36: 2065-2065. DOI: 10.1200/Jco.2018.36.15_Suppl.2065 |
0.322 |
|
| 2018 |
Maraka S, Groves MD, Mammoser AG, Melguizo-Gavilanes I, Conrad CA, Tremont-Lukats I, Loghin ME, O'Brien BJ, Puduvalli VK, Sulman EP, Hess KR, Aldape KD, Gilbert MR, De Groot JF, Yung WKA, et al. Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma. Journal of Clinical Oncology. 36: 2044-2044. DOI: 10.1200/Jco.2018.36.15_Suppl.2044 |
0.325 |
|
| 2018 |
Shaw V, Piao Y, Park SY, Dong J, Martinez-Ledesma E, Carrillo C, Henry V, Ezhilarasan R, Sulman E, Balasubramaniyan V, Groot JFd. Abstract 4858: Efficacy of the protein arginine methyltransferase PRMT5 inhibitor GSK591 in glioma stem-like cells Cancer Research. 78: 4858-4858. DOI: 10.1158/1538-7445.Am2018-4858 |
0.422 |
|
| 2018 |
Dong J, Martinez-Ledesma E, Nguyen N, Wu S, Piao Y, Tiao N, Park SY, Brunell D, Stephan C, Verhaak R, Sulman E, Balasubramaniyan V, Groot JFd. Abstract 4819: High-throughput screening of glioma stem-like cells (GSCs) identifies synergistic therapeutic combination of FGFR inhibitor and CDK4/6 inhibitor Cancer Research. 78: 4819-4819. DOI: 10.1158/1538-7445.Am2018-4819 |
0.373 |
|
| 2018 |
Johnson KC, Barthel FP, Tang M, Amin S, Wang Q, Sulman EP, Rai K, Verhaak RGW. Abstract 4355: Identification and functional characterization of glioma structural variants Cancer Research. 78: 4355-4355. DOI: 10.1158/1538-7445.Am2018-4355 |
0.411 |
|
| 2018 |
Hossain MB, Shifat R, Kim DK, Rivera-Molina Y, Martinez FP, Jiang H, Nguyen T, Johnson DG, Bedford MT, Hung M, Sulman EP, Lang F, Sawaya R, Fueyo J, Gomez-Manzano C. Abstract 3205: Histone tyrosine phosphorylation determines glioblastoma cell survival Cancer Research. 78: 3205-3205. DOI: 10.1158/1538-7445.Am2018-3205 |
0.381 |
|
| 2018 |
Dong J, Martinez-Ledesma E, Nguyen N, Carrillo C, Piao Y, Henry V, Park SY, Tiao N, Stephan C, Verhaak R, Sulman E, Balasubramaniyan V, Groot JFd. Abstract 2945: Arsenic trioxide sensitizes glioma stem cells to brain penetrant PI3K and mTOR inhibitor GDC-0084 Cancer Research. 78: 2945-2945. DOI: 10.1158/1538-7445.Am2018-2945 |
0.407 |
|
| 2018 |
Huang T, Kim CK, Alvarez AA, Pangeni RP, Wan X, song x, shi T, Yongyong Y, Sastry N, Horbinski C, Lu S, Stupp R, Kessler J, Nishikawa R, Nakano I, ... Sulman E, et al. Abstract 1122: MST4 phosphorylation of ATG4B regulates autophagic activity, tumorigenicity, and radio resistance in glioblastoma Cancer Research. 78: 1122-1122. DOI: 10.1158/1538-7445.Am2018-1122 |
0.416 |
|
| 2018 |
Zinn PO, Singh SK, Kotrotsou A, Hassan I, Luedi MM, Thomas G, Elshafeey N, Mosley J, Elakkad A, Idris T, Gumin J, Fuller GN, de Groot J, Baladandayuthapani V, Sulman EP, et al. 100 Toward the Co-clinical Glioblastoma Treatment Paradigm—Radiomic Machine Learning Identifies Glioblastoma Gene Expression in Patients and Corresponding Xenograft Tumor Models Neurosurgery. 65: 80-80. DOI: 10.1093/Neuros/Nyy303.100 |
0.358 |
|
| 2018 |
Bronk L, Ezhilarasan R, Ding Y, Zhang Z, Sulman E. Rdna-02. Tumor Treating Fields Differentially Alter Homologous Recombination In Patient Derived Glioma Cells Versus Established Lines Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.918 |
0.41 |
|
| 2018 |
Mittal S, Shaw V, Piao Y, Park SY, Sriram S, Dong J, Martinez-Ledesma E, Henry V, Ezhilarasan R, Sulman E, Balasubramaniyan V, Groot Jd. Exth-12. Effect Of The Protein Arginine Methyltransferase Prmt5 Inhibition In Glioma Stem-Like Cells Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.361 |
0.337 |
|
| 2018 |
Wu S, Gao F, Zheng S, Zhang C, Martinez-Ledesma JE, Ezhilarasan R, Ding J, Li X, Feng N, Sulman E, Verhaak R, Groot Jd, Heffernan T, Yung WKA, Koul D. Ddis-03. Egfr Amplification Induced Increased Dna Damage Response And Predicted Selective Sensitivity To Talazoparib (Parp Inhibitor) In Glioblastoma Stem-Like Cells Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.282 |
0.332 |
|
| 2018 |
Vaubel R, Tian S, Remonde D, Schroeder M, Kollmeyer T, Peng S, Mladek A, Carlson B, Ma D, Kitange G, Evers L, Decker P, Kosel M, Berens M, Klee E, ... ... Sulman E, et al. TMOD-18. THE PATIENT DERIVED XENOGRAFT NATIONAL RESOURCE: A COMPREHENSIVE COLLECTION OF HIGH-GRADE GLIOMA MODELS FOR PRE-CLINICAL AND TRANSLATIONAL STUDIES Neuro-Oncology. 20: vi272-vi272. DOI: 10.1093/Neuonc/Noy148.1130 |
0.307 |
|
| 2018 |
Rao G, Latha K, Yan J, Yang Y, Manyam G, Ezhilarasan R, Sulman E, Rao A, Heimberger A, Li S. TMIC-33. THE ROLE OF FIBRINOGEN-LIKE PROTEIN 2 ON IMMUNOSUPPRESSION AND MALIGNANT PROGRESSION IN GLIOMA Neuro-Oncology. 20: vi263-vi263. DOI: 10.1093/Neuonc/Noy148.1092 |
0.302 |
|
| 2018 |
Farooqi A, Yang J, Sharin V, Huse JT, Sulman E. Stem-05. Identification Of Patient-Derived Glioblastoma Stem Cell (Gsc) Lines With The Alternative Lengthening Of Telomeres Phenotype Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.1012 |
0.333 |
|
| 2017 |
Mostovenko E, Végvári Á, Rezeli M, Lichti CF, Fenyö D, Wang Q, Lang FF, Sulman EP, Sahlin KB, Marko-Varga G, Nilsson CL. Large Scale Identification of Variant Proteins in Glioma Stem Cells. Acs Chemical Neuroscience. PMID 29254333 DOI: 10.1021/Acschemneuro.7B00362 |
0.463 |
|
| 2017 |
Huang T, Kim CK, Alvarez AA, Pangeni RP, Wan X, Song X, Shi T, Yang Y, Sastry N, Horbinski CM, Lu S, Stupp R, Kessler JA, Nishikawa R, Nakano I, ... Sulman EP, et al. MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma. Cancer Cell. 32: 840-855.e8. PMID 29232556 DOI: 10.1016/J.Ccell.2017.11.005 |
0.387 |
|
| 2017 |
Fang P, Boehling NS, Koay EJ, Bucheit AD, Jakob JA, Settle SH, Brown PD, Davies MA, Sulman EP. Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy. Journal of Neuro-Oncology. PMID 29198052 DOI: 10.1007/S11060-017-2695-2 |
0.312 |
|
| 2017 |
Moreno M, Pedrosa L, Paré L, Pineda E, Bejarano L, Martínez J, Balasubramaniyan V, Ezhilarasan R, Kallarackal N, Kim SH, Wang J, Audia A, Conroy S, Marin M, Ribalta T, ... ... Sulman EP, et al. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma. Cell Reports. 21: 2183-2197. PMID 29166609 DOI: 10.1016/J.Celrep.2017.10.083 |
0.399 |
|
| 2017 |
Boonyawan K, Hess KR, Yang J, Long L, Wang Q, Ezhilarasan R, Auia A, Alfaro-Munoz KD, de Groot JF, Bhat KP, Sulman EP. A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma. Oncotarget. 8: 90488-90495. PMID 29163847 DOI: 10.18632/Oncotarget.21799 |
0.342 |
|
| 2017 |
Ong DST, Hu B, Ho YW, Sauvé CG, Bristow CA, Wang Q, Multani AS, Chen P, Nezi L, Jiang S, Gorman CE, Monasterio MM, Koul D, Marchesini M, Colla S, ... ... Sulman EP, et al. PAF promotes stemness and radioresistance of glioma stem cells. Proceedings of the National Academy of Sciences of the United States of America. 114: E9086-E9095. PMID 29073105 DOI: 10.1073/Pnas.1708122114 |
0.408 |
|
| 2017 |
An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, ... ... Sulman EP, et al. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTL-4 treatment is associated with improved intracranial control. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28916225 DOI: 10.1016/J.Radonc.2017.08.009 |
0.333 |
|
| 2017 |
Li M, Xiao A, Floyd D, Olmez I, Lee J, Godlewski J, Bronisz A, Bhat KPL, Sulman EP, Nakano I, Purow B. CDK4/6 inhibition is more active against the glioblastoma proneural subtype. Oncotarget. 8: 55319-55331. PMID 28903422 DOI: 10.18632/Oncotarget.19429 |
0.434 |
|
| 2017 |
Wang Y, Wu S, Zheng S, Wang S, Wali A, Ezhilarasan R, Sulman EP, Koul D, Alfred Yung WK. APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death. Oncotarget. 8: 54285-54296. PMID 28903341 DOI: 10.18632/Oncotarget.17348 |
0.439 |
|
| 2017 |
Guerrero PA, Tchaicha JH, Chen Z, Morales JE, McCarty N, Wang Q, Sulman EP, Fuller G, Lang FF, Rao G, McCarty JH. Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression. Oncogene. PMID 28783169 DOI: 10.1038/Onc.2017.248 |
0.452 |
|
| 2017 |
Li M, Xiao A, Floyd D, Olmez I, Lee J, Godlewski J, Bronisz A, Bhat KPL, Sulman EP, Nakano I, Purow B. CDK4/6 inhibition is more active against the glioblastoma proneural subtype. Oncotarget. PMID 28751617 DOI: 10.18632/oncotarget.19429 |
0.323 |
|
| 2017 |
Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel F, Cho HJ, Lin YH, Satani N, Martinez-Ledesma E, ... ... Sulman EP, et al. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell. 32: 42-56.e6. PMID 28697342 DOI: 10.1016/J.Ccell.2017.06.003 |
0.327 |
|
| 2017 |
Canella A, Welker AM, Yoo JY, Xu J, Abbas FS, Kesanakurti D, Nagarajan P, Beattie CE, Sulman EP, Liu JL, Gumin J, Lang FF, Gurcan M, Kaur B, Sampath D, et al. Efficacy of Onalespib a Long-acting Second Generation HSP90 Inhibitor as a Single Agent and in Combination with Temozolomide Against Malignant Gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28679777 DOI: 10.1158/1078-0432.Ccr-16-3151 |
0.376 |
|
| 2017 |
Wu J, Frady LN, Bash RE, Cohen SM, Schorzman AN, Su YT, Irvin DM, Zamboni WC, Wang X, Frye SV, Ewend MG, Sulman EP, Gilbert MR, Earp HS, Miller CR. MerTK as a therapeutic target in glioblastoma. Neuro-Oncology. PMID 28605477 DOI: 10.1093/Neuonc/Nox111 |
0.3 |
|
| 2017 |
Wang Y, Wu S, Zheng S, Wang S, Wali A, Ezhilarasan R, Sulman EP, Koul D, Yung WKA. APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death. Oncotarget. PMID 28493832 DOI: 10.18632/oncotarget.17348 |
0.33 |
|
| 2017 |
Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP, Lang FF. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro-Oncology. 19: 660-668. PMID 28453745 DOI: 10.1093/Neuonc/Now239 |
0.735 |
|
| 2017 |
Koul D, Wang S, Wu S, Saito N, Zheng S, Gao F, Kaul I, Setoguchi M, Nakayama K, Koyama K, Shiose Y, Sulman EP, Hirota Y, Yung WKA. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma. Oncotarget. 8: 21741-21753. PMID 28423515 DOI: 10.18632/Oncotarget.15566 |
0.412 |
|
| 2017 |
Ballester LY, Fuller GN, Powell SZ, Sulman EP, Patel KP, Luthra R, Routbort MJ. Retrospective Analysis of Molecular and Immunohistochemical Characterization of 381 Primary Brain Tumors. Journal of Neuropathology and Experimental Neurology. 76: 179-188. PMID 28395087 DOI: 10.1093/Jnen/Nlw119 |
0.355 |
|
| 2017 |
Powell RT, Olar A, Narang S, Rao G, Sulman E, Fuller GN, Rao A. Identification of Histological Correlates of Overall Survival in Lower Grade Gliomas Using a Bag-of-words Paradigm: A Preliminary Analysis Based on Hematoxylin & Eosin Stained Slides from the Lower Grade Glioma Cohort of The Cancer Genome Atlas. Journal of Pathology Informatics. 8: 9. PMID 28382223 DOI: 10.4103/Jpi.Jpi_43_16 |
0.374 |
|
| 2017 |
McNeill RS, Canoutas DA, Stuhlmiller TJ, Dhruv HD, Irvin DM, Bash RE, Angus SP, Herring LE, Simon JM, Skinner KR, Limas JC, Chen X, Schmid RS, Siegel MB, Van Swearingen AE, ... ... Sulman EP, et al. Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma. Neuro-Oncology. PMID 28379424 DOI: 10.1093/Neuonc/Nox044 |
0.331 |
|
| 2017 |
Thomas JG, Parker Kerrigan BC, Hossain A, Gumin J, Shinojima N, Nwajei F, Ezhilarasan R, Love P, Sulman EP, Lang FF. Ionizing radiation augments glioma tropism of mesenchymal stem cells. Journal of Neurosurgery. 1-9. PMID 28362237 DOI: 10.3171/2016.9.Jns16278 |
0.393 |
|
| 2017 |
Olar A, Wani KM, Wilson CD, Zadeh G, DeMonte F, Jones DT, Pfister SM, Sulman EP, Aldape KD. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathologica. PMID 28130639 DOI: 10.1007/S00401-017-1678-X |
0.376 |
|
| 2017 |
Boonyawan K, Yang J, Long L, Wang Q, Ezhilarasan R, Alessandra A, Hess KR, Alfaro K, Groot JFD, Bhat K, Sulman EP. Relative thrombocytosis following chemoradiation of patients with glioblastoma to predict survival. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E13527 |
0.386 |
|
| 2017 |
Hossain MB, Shifat R, Li J, Rivera-Mokina Y, Martinez FP, Johnson DG, Bedford MT, Hung M, Sulman EP, Lang F, Sawaya R, Fueyo J, Gomez-Manzano C. Abstract 5854: TIE2-mediated epigenetic marks regulate therapeutic resistance of glioblastoma Cancer Research. 77: 5854-5854. DOI: 10.1158/1538-7445.Am2017-5854 |
0.304 |
|
| 2017 |
Latha K, Yan J, Yang Y, Gressot LV, Kong L, Manyam G, Ezhilarasan R, Wang Q, Sulman EP, Xu J, Davis RE, Huang S, Fuller GN, Rao A, Heimberger AB, et al. Abstract 5606: Fibrinogen-like protein 2 drives malignant tumor progression in glioma Cancer Research. 77: 5606-5606. DOI: 10.1158/1538-7445.Am2017-5606 |
0.463 |
|
| 2017 |
Yang J, Wang Q, Long L, Ezhilarasan R, Sulman E. Abstract 3348: UniD: unified and integrated diagnostic pipeline for malignant gliomas based on DNA methylation data Cancer Research. 77: 3348-3348. DOI: 10.1158/1538-7445.Am2017-3348 |
0.414 |
|
| 2017 |
Zhang C, Juan M, Ding J, Gao F, Wu S, Li X, Sulman EP, Koul D, Yung WA. Abstract 2798: Identification of gamma secretase inhibitor (GSI)-responsive GBM patients: Involvement of NOTCH, p53, and PI3K/MAPK signaling Cancer Research. 77: 2798-2798. DOI: 10.1158/1538-7445.Am2017-2798 |
0.397 |
|
| 2017 |
Zinn PO, Luedi MM, Singh SK, Mosley J, Hassan I, Hatami M, Gumin J, Andereggen L, Sulman EP, Lang FF, Stueber F, Fuller GN, Colen RR. 222 Dexamethasone Induces Mesenchymal Trans-differentiation and Promotes Hallmarks of Cancer in Glioblastoma Neurosurgery. 64: 260-261. DOI: 10.1093/Neuros/Nyx417.222 |
0.306 |
|
| 2017 |
Yang J, Wang Q, Long L, Ezhilarasan R, Sulman E. GENE-36. ACCURATE DETECTION OF TERT PROMOTER MUTATION IN GLIOMAS USING INFINIUM DNA METHYLATION ARRAYS IDENTIFIES NOVEL EPIGENETIC ASSOCIATION Neuro-Oncology. 19: vi100-vi100. DOI: 10.1093/Neuonc/Nox168.409 |
0.302 |
|
| 2017 |
Danussi C, Bose P, Parthasarathy P, Silberman P, Arnam JSV, Vitucci M, Tang O, Heguy A, Chan T, Sulman E, Lang F, Creighton CJ, Deneen B, Miller CR, Picketts D, et al. Gene-24. Atrx Deficiency In Glioma Cells Of Origin Promotes Disease-Defining Phenotypes By Way Of Global Epigenomic Remodeling Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.398 |
0.33 |
|
| 2017 |
Zhang Z, Ezhilarasan R, Ding Y, Wang Q, Yang J, Long L, Verhaak R, Sulman E. DRES-04. DEVELOPMENT OF A CRISPR-CAS9D10A TARGETABLE, HIGH-COMPLEXITY, SINGLE-CELL BARCODING APPROACH FOR ISOLATION OF TREATMENT RESISTANT SUBCLONES FROM HETEROGENOUS MALIGNANT GLIOMAS Neuro-Oncology. 19: vi64-vi64. DOI: 10.1093/Neuonc/Nox168.262 |
0.328 |
|
| 2017 |
Wang Q, Ezhilarasan R, Goodman L, Eskilsson E, Yang J, Gumin J, Zheng S, Tang M, Jaffari M, Long L, Yoshihara K, Sun P, Heffernan T, Yung WKA, Draetta G, ... ... Sulman E, et al. TMOD-04. A COMPREHENSIVE GENOMIC LANDSCAPE OF GLIOMA SPHEROID CULTURES RECAPITULATES THE HETEROGENEITY OF GLIOBLASTOMA AND IDENTIFIES DNA METHYLATION PREDICTORS OF RADIOTHERAPY RESPONSE Neuro-Oncology. 19: vi255-vi255. DOI: 10.1093/Neuonc/Nox168.1043 |
0.689 |
|
| 2017 |
Wang Q, Hu B, Hu X, Squatrito M, Scarpace L, deCarvalho AC, Lyu S, Li P, Li Y, Barthel FP, Cho HJ, Lin Y, Satani N, Martinez-Ledesma E, Zheng S, ... ... Sulman E, et al. TMIC-22. DECIPHERING GLIOMA INTRINSIC TRANSCRIPTIONAL SUBTYPES IDENTIFIES TUMOR EVOLUTION ASSOCIATES WITH CHANGES IN IMMUNE-MICROENVIRONMENT Neuro-Oncology. 19: vi247-vi248. DOI: 10.1093/Neuonc/Nox168.1011 |
0.359 |
|
| 2017 |
McCarty J, Sulman E, Rao G, Wang Q, Lang F, Guerrero P. Angi-17. Glioblastoma Stem Cells Exploit The Alphavbeta8 Integrin-Tgfbeta Signaling Axis To Drive Tumor Initiation And Progression Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.095 |
0.398 |
|
| 2016 |
Reardon DA, Lassman AB, van den Bent M, Kumthekar P, Merrell R, Scott AM, Fichtel L, Sulman EP, Gomez E, Fischer J, Lee HJ, Munasinghe W, Xiong H, Mandich H, Roberts-Rapp L, et al. Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma. Neuro-Oncology. PMID 28039367 DOI: 10.1093/Neuonc/Now257 |
0.345 |
|
| 2016 |
Shahar T, Rozovski U, Hess KR, Hossain A, Gumin J, Gao F, Fuller GN, Goodman L, Sulman EP, Lang FF. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival. Neuro-Oncology. PMID 27994067 DOI: 10.1093/neuonc/now239 |
0.317 |
|
| 2016 |
Sulman EP, Ismaila N, Armstrong TS, Tsien C, Batchelor TT, Cloughesy T, Galanis E, Gilbert M, Gondi V, Lovely M, Mehta M, Mumber MP, Sloan A, Chang SM. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016707562. PMID 27893327 DOI: 10.1200/Jco.2016.70.7562 |
0.321 |
|
| 2016 |
Hu B, Wang Q, Wang YA, Hua S, Sauvé CG, Ong D, Lan ZD, Chang Q, Ho YW, Monasterio MM, Lu X, Zhong Y, Zhang J, Deng P, Tan Z, ... ... Sulman EP, et al. Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth. Cell. 167: 1281-1295.e18. PMID 27863244 DOI: 10.1016/J.Cell.2016.10.039 |
0.439 |
|
| 2016 |
Hossain MB, Shifat R, Johnson DG, Bedford MT, Gabrusiewicz KR, Cortes-Santiago N, Luo X, Lu Z, Ezhilarasan R, Sulman EP, Jiang H, Li SS, Lang FF, Tyler J, Hung MC, et al. TIE2-mediated tyrosine phosphorylation of H4 regulates DNA damage response by recruiting ABL1. Science Advances. 2: e1501290. PMID 27757426 DOI: 10.1126/Sciadv.1501290 |
0.302 |
|
| 2016 |
Luedi MM, Singh SK, Mosley JC, Hatami M, Gumin J, Sulman EP, Lang FF, Stueber F, Zinn PO, Colen RR. A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients. Journal of Neurosurgical Anesthesiology. PMID 27653222 DOI: 10.1097/Ana.0000000000000368 |
0.454 |
|
| 2016 |
Shingu T, Holmes L, Henry V, Wang Q, Latha K, Gururaj AE, Gibson LA, Doucette T, Lang FF, Rao G, Yuan L, Sulman EP, Farrell NP, Priebe W, Hess KR, et al. Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells. Journal of Translational Medicine. 14: 46. PMID 26861698 DOI: 10.1186/S12967-016-0803-2 |
0.387 |
|
| 2016 |
Kim SH, Ezhilarasan R, Phillips E, Gallego-Perez D, Sparks A, Taylor D, Ladner K, Furuta T, Sabit H, Chhipa R, Cho JH, Mohyeldin A, Beck S, Kurozumi K, Kuroiwa T, ... ... Sulman EP, et al. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner. Cancer Cell. 29: 201-213. PMID 26859459 DOI: 10.1016/J.Ccell.2016.01.005 |
0.328 |
|
| 2016 |
Zinn P, Singh S, Luedi MM, Zandi F, Kotrotsou A, Hatami M, Thomas G, Elakkad A, Gumin J, Sulman EP, Lang F, Piwnica-Worms D, Colen RR. Abstract 4217: First pre-clinical validation of radiogenomics in glioblastoma Cancer Research. 76: 4217-4217. DOI: 10.1158/1538-7445.Am2016-4217 |
0.337 |
|
| 2016 |
Nguyen C, Piao Y, Martinez-Ledesma JE, Dong J, Park SY, Verhaak R, Sulman E, Groot JFD. Abstract 2815: Antitumor activity of CDK4/6 inhibition in combination with radiation therapy on glioblastoma stem cells Cancer Research. 76: 2815-2815. DOI: 10.1158/1538-7445.Am2016-2815 |
0.404 |
|
| 2016 |
Wang Q, Ezhilarasan R, Eskilsson E, Gumin J, Yang J, Jaffari M, Tang M, Aldape KD, Lang FF, Verhaak RGW, Sulman EP. Abstract 1646: A glioblastoma methylation assay (GaMA) developedfrom genomic analysis of glioma spheroid cultures predicts response toradiation therapy in patients with glioblastoma Cancer Research. 76: 1646-1646. DOI: 10.1158/1538-7445.Am2016-1646 |
0.404 |
|
| 2016 |
Zhang J, Wu C, Zhang J, Fujimoto J, Song X, Mao X, Sun H, Seth S, Thornton R, Coyle M, Little L, Gumbs C, Behrens C, Chow C, Sulman E, et al. Abstract 156: Integrated exome and transcriptome sequencing of primary lung cancers and paired distant metastases Cancer Research. 76: 156-156. DOI: 10.1158/1538-7445.Am2016-156 |
0.386 |
|
| 2016 |
Colen RR, Luedi M, Singh SK, Hassan I, Gumin J, Sulman EP, Lang FF, Zinn PO. Abstract 1505: Radiogenomics defines key genomic network driving GBM invasion Cancer Research. 76: 1505-1505. DOI: 10.1158/1538-7445.Am2016-1505 |
0.388 |
|
| 2016 |
Wang Q, Hu X, Muller F, Kim H, Squatrito M, Mikkelsen T, Scarpace L, Barthel F, Lin Y, Satani N, Martinez-Ledesma E, Chang E, Olar A, Hu B, deCarvalho A, ... ... Sulman E, et al. TMIC-14. TUMOR EVOLUTION OF GLIOMA INTRINSIC GENE EXPRESSION SUBTYPE ASSOCIATES WITH IMMUNOLOGICAL CHANGES IN THE MICROENVIRONMENT Neuro-Oncology. 18: vi202-vi202. DOI: 10.1093/Neuonc/Now212.854 |
0.393 |
|
| 2016 |
Audia A, Minata M, Guo X, Mukheef F, Patel H, Ezhilarasan R, Sulman E, Nakano I, Bhat K. Stmc-36. Cd109 Regulates Tumor Propagation Of Radio-Resistant Glioma Stem Cells Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.799 |
0.406 |
|
| 2016 |
Alvarez A, Huang T, Pangeni R, Lu S, Brennan C, Sulman E, Lu X, Nakano I, Zhang W, Zhang Z, Hu B, Cheng S. STMC-35. DIVERGENT Wnt SIGNALING REGULATES GLIOMA STEM CELLS AND TUMOR PHENOTYPE Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.798 |
0.405 |
|
| 2016 |
Olar A, Ezhilarasan R, Mehrotra M, Manekia J, Singh R, Sulman E, Luthra R. Mpth-46. A Pilot Study Identifying Circulating Cell-Free Tumor Dna Alterations In Patients With Glioblastoma Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.481 |
0.413 |
|
| 2016 |
Yang J, Wang Q, Long L, Ezhilarasan R, Olar A, Sulman E. Gent-39. A Unified Diagnostic Platform For Malignant Gliomas To Assess Radiation Response, Tcga Subclass, Copy Number Alteration (Cna), G-Cimp Status, And Mgmt Promoter Hypermethylation Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.345 |
0.327 |
|
| 2015 |
Gupta SK, Kizilbash SH, Carlson BL, Mladek AC, Boakye-Agyeman F, Bakken KK, Pokorny JL, Schroeder MA, Decker PA, Cen L, Eckel-Passow JE, Sarkar G, Ballman KV, Reid JM, Jenkins RB, ... ... Sulman EP, et al. Delineation of MGMT Hypermethylation as a Biomarker for Veliparib-Mediated Temozolomide-Sensitizing Therapy of Glioblastoma. Journal of the National Cancer Institute. 108. PMID 26615020 DOI: 10.1093/Jnci/Djv369 |
0.333 |
|
| 2015 |
Sathyan P, Zinn PO, Marisetty AL, Liu B, Kamal MM, Singh SK, Bady P, Lu L, Wani KM, Veo BL, Gumin J, Kassem DH, Robinson F, Weng C, Baladandayuthapani V, ... ... Sulman EP, et al. Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 15097-112. PMID 26558781 DOI: 10.1523/Jneurosci.1265-15.2015 |
0.361 |
|
| 2015 |
Reddy JP, Dawood S, Mitchell M, Debeb BG, Bloom E, Gonzalez-Angulo AM, Sulman EP, Buchholz TA, Woodward WA. Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26482599 DOI: 10.1016/J.Radonc.2015.10.009 |
0.305 |
|
| 2015 |
Balasubramaniyan V, Vaillant B, Wang S, Gumin J, Butalid ME, Sai K, Mukheef F, Kim SH, Boddeke HW, Lang F, Aldape K, Sulman EP, Bhat KP, Colman H. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting. Oncotarget. 6: 31007-17. PMID 26307681 DOI: 10.18632/Oncotarget.5219 |
0.384 |
|
| 2015 |
Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, ... ... Sulman EP, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. 372: 2481-98. PMID 26061751 DOI: 10.1056/Nejmoa1402121 |
0.312 |
|
| 2015 |
Olar A, Sulman EP. Molecular Markers in Low-Grade Glioma-Toward Tumor Reclassification. Seminars in Radiation Oncology. 25: 155-163. PMID 26050585 DOI: 10.1016/J.Semradonc.2015.02.006 |
0.396 |
|
| 2015 |
Hossain A, Gumin J, Gao F, Figueroa J, Shinojima N, Takezaki T, Priebe W, Villarreal D, Kang SG, Joyce C, Sulman E, Wang Q, Marini FC, Andreeff M, Colman H, et al. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway. Stem Cells (Dayton, Ohio). 33: 2400-15. PMID 25966666 DOI: 10.1002/Stem.2053 |
0.352 |
|
| 2015 |
Kim SH, Joshi K, Ezhilarasan R, Myers TR, Siu J, Gu C, Nakano-Okuno M, Taylor D, Minata M, Sulman EP, Lee J, Bhat KP, Salcini AE, Nakano I. EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner. Stem Cell Reports. 4: 226-38. PMID 25601206 DOI: 10.1016/J.Stemcr.2014.12.006 |
0.448 |
|
| 2015 |
Lichti CF, Mostovenko E, Wadsworth PA, Lynch GC, Pettitt BM, Sulman EP, Wang Q, Lang FF, Rezeli M, Marko-Varga G, Végvári Á, Nilsson CL. Systematic identification of single amino acid variants in glioma stem-cell-derived chromosome 19 proteins. Journal of Proteome Research. 14: 778-86. PMID 25399873 DOI: 10.1021/Pr500810G |
0.33 |
|
| 2015 |
Olar A, Wani KM, Sulman EP, Mansouri A, Zadeh G, Wilson CD, DeMonte F, Fuller GN, Aldape KD. Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma. Brain Pathology (Zurich, Switzerland). 25: 266-75. PMID 25040885 DOI: 10.1111/Bpa.12174 |
0.381 |
|
| 2015 |
Sarkaria JN, Gupta S, Kizilbash SH, Carlson B, Mladek A, Bakken K, Schroeder MA, Decker PA, Sulman EP, Eckel-Passow J, Kitange G, Jenkins RB. Delineation of MGMT promoter hypermethylation as a predictive biomarker for the A071102 clinical trial of veliparib combined with temozolomide (TMZ) using patient-derived xenograft (PDX) GBM models. Journal of Clinical Oncology. 33: 2052-2052. DOI: 10.1200/Jco.2015.33.15_Suppl.2052 |
0.317 |
|
| 2015 |
Dong J, Nguyen N, Ezhilarasan R, Wu S, Piao Y, Park SY, Tiao N, Stephan C, Sulman EP, Groot JFd. Abstract 695: Synergistic antitumor effects of polo like kinase inhibitor volasertib in combination with ionizing radiation in glioblastoma Cancer Research. 75: 695-695. DOI: 10.1158/1538-7445.Am2015-695 |
0.381 |
|
| 2015 |
Jiang W, Rodriguez Y, Boehling NS, Prabhu SS, Kim BYS, Hwu P, Sulman EP, Brown PD, Li J. Abstract 532: Circulating myeloid precursor profile as potential marker to differentiate radiation changes from tumor recurrence after brain stereotactic radiosurgery Cancer Research. 75: 532-532. DOI: 10.1158/1538-7445.Am2015-532 |
0.441 |
|
| 2015 |
Olar A, Wani K, Diefes K, Heathcock L, Thuijl Hv, Gilbert M, Armstrong T, Sulman E, Cahill D, Reijneveld J, Ylstra B, Wesseling P, Aldape K. Abstract 5270: IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas Cancer Research. 75: 5270-5270. DOI: 10.1158/1538-7445.Am2015-5270 |
0.377 |
|
| 2015 |
Wang Q, Ezhilarasan R, Goodman LD, Gumin J, Zheng S, Yoshihara K, Sun P, Yang J, Heffernan T, Draetta G, Aldape KD, Lang FF, Verhaak RGW, Sulman EP. Abstract 4795: A novel gene fusion in glioblastoma and a radiation response methylation signature identified by genomic characterization of glioma sphere-forming cells Cancer Research. 75: 4795-4795. DOI: 10.1158/1538-7445.Am2015-4795 |
0.769 |
|
| 2015 |
Shingu T, Holmes L, Henry V, Latha K, Gururaj AE, Gibson LA, Doucette T, Lang FF, Rao G, Yuan L, Sulman EP, Farrell NP, Priebe W, Hess KR, Wang YA, et al. Abstract 3483: Synergistic combination therapy with molecular targeted drugs in glioma stem-like cells Cancer Research. 75: 3483-3483. DOI: 10.1158/1538-7445.Am2015-3483 |
0.437 |
|
| 2015 |
Hossain MB, Shifat R, Johnson DG, Bedford MT, Hung M, Cortes-Santiago N, Gabrusiewicz K, Gumin J, Ezhilarasan R, Sulman EP, Lang F, Sawaya R, Yung WKA, Fueyo J, Gomez-Manzano C. Abstract 3298: ABL1 is required for Tie2-mediated DNA repair in brain tumor stem cells Cancer Research. 75: 3298-3298. DOI: 10.1158/1538-7445.Am2015-3298 |
0.442 |
|
| 2015 |
Moreno M, Pineda E, Martínez J, Bejarano L, Balasubramaniyan V, Ezhilarasan R, Kallarackal N, Kim S, Paré L, Tortosa A, Gómez-Manzano C, Graus F, Sulman E, Piao X, Nakano I, et al. Stem-08Inhibition Of The Neural Stem Cell/Oligodendrocyte Progenitor Factor Gpr56 Promotes The Proneural To Mesenchymal Transition And Radioresistance In Glioblastoma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov234.08 |
0.41 |
|
| 2015 |
Hossain MB, Shifat R, Johnson DG, Bedford MT, Hung M, Gabrusiewicz K, Gumin J, Ezhilarasan R, Sulman EP, Lang F, Tyler J, Sawaya R, Yung WA, Fueyo J, Gomez-Manzano C. RTRB-10TYROSINE KINASE RECEPTOR TIE2 REGULATES DNA REPAIR THROUGH THE PROTO-ONCOGENE ABL1 IN BRAIN TUMOR STEM CELLS Neuro-Oncology. 17: v197.2-v197. DOI: 10.1093/Neuonc/Nov231.10 |
0.447 |
|
| 2015 |
Wefel J, Sulman E, Zhou R, Liu Y, Scheurer M, Bondy M. NCO-16GENETIC MODULATION OF NEUROCOGNITIVE DECLINE IN GLIOMA PATIENTS Neuro-Oncology. 17: v149.3-v149. DOI: 10.1093/Neuonc/Nov223.16 |
0.329 |
|
| 2015 |
Olar A, Goodman L, Wani K, Boehling N, DeMonte F, Aldape K, Sulman E. Mpth-25An 18-Gene Expression Signature Predicts Recurrence-Free Survival In Meningioma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov222.25 |
0.419 |
|
| 2015 |
Wang Q, Hu X, Muller F, Kim H, Mikkelsen T, Scarpace L, Lin Y, Satani N, Chang E, Olar A, Decarvalho A, Eskilsson E, Rabadan R, Iavarone A, Finocchiaro G, ... ... Sulman E, et al. MTR-19A MACROPHAGE-/MICROGLIAL-RICH TUMOR MICROENVIRONMENT MIMICS PRONEURAL TO MESENCHYMAL TRANSITION IN GLIOBLASTOMA Neuro-Oncology. 17: v128.3-v128. DOI: 10.1093/Neuonc/Nov219.19 |
0.458 |
|
| 2015 |
Wang Q, Eskilsson E, Ezhilarasan R, Zheng S, Gumin J, Heffernan T, Draetta G, Lang F, Verhaak R, Sulman E. Geno-36Glioma Sphere-Forming Cells Reveal Intrinsic Global Hypermethylation Associated With Gbm Radiation Resistance Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov215.36 |
0.369 |
|
| 2015 |
Yang J, Wang Q, Ezhilarasan R, Jaffari M, Olar A, Verhaak R, Sulman E. Epig-19A Methylation Classification Of Glioblastoma That Accurately Predicts Gene Expression Subtype. Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov214.19 |
0.353 |
|
| 2015 |
Eskilsson E, Wang Q, Ezhilarasan R, Bhat KP, Tang M, Goodman LD, Aldape KD, Verhaak RG, Sulman EP. Epig-05Radioresistance Of Podoplanin-Expressing Glioma Stem Cells Is Associated With Ezh2-Driven Polycomb Repressive Complex Activity Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov214.05 |
0.747 |
|
| 2015 |
Hashimoto Y, Yaghi NK, Wei J, Huang N, Ezhilarasan R, Kong L, Zhou S, Chivukula P, Webb DC, Priebe W, Payne JE, Sulman EP, Heimberger AB. BMET-14STAT3 INHIBITION ENHANCES THERAPEUTIC EFFICACY OF RADIATION TREATMENT AGAINST ESTABLISHED BRAIN METASTASIS IN MURINE MELANOMA MODEL Neuro-Oncology. 17: v47.5-v48. DOI: 10.1093/Neuonc/Nov208.14 |
0.356 |
|
| 2015 |
Koul D, Wang S, Saito N, Zheng S, Wu S, Setoguchi M, Nakayama K, Koyama K, Shiose Y, Sulman EP, Hirota Y, Yung WKA. Atps-46Preclinical Therapeutic Efficacy Of A Novel Blood-Brain Barrier-Penetrant Dual Pi3K/Mtor Inhibitor With Preferential Response In Pi3K/Pten Mutant Glioma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov204.46 |
0.412 |
|
| 2015 |
Dong J, Ezhilarasan R, Wu S, Sulman E, de Groot J. ATPS-20AURORA KINASE B INHIBITOR AT9283 ENHANCED RADIATION THERAPY IN GLIOBLASTOMA Neuro-Oncology. 17: v22.3-v22. DOI: 10.1093/Neuonc/Nov204.20 |
0.419 |
|
| 2015 |
Dong J, Nguyen N, Ezhilarasan R, Wu S, Henry V, Piao Y, Park SY, Tiao N, Stephan C, Sulman E, de Groot J. ATPS-19POLO LIKE KINASE INHIBITOR VOLASERTIB SYNERGISTICALLY IMPROVE RADIATION EFFICACY IN GLIOBLASTOMA Neuro-Oncology. 17: v22.2-v22. DOI: 10.1093/Neuonc/Nov204.19 |
0.402 |
|
| 2015 |
Lichti CF, Wildburger NC, Shavkunov AS, Mostovenko E, Liu H, Sulman EP, Nilsson CL. The proteomic landscape of glioma stem-like cells Eupa Open Proteomics. 8: 85-93. DOI: 10.1016/J.Euprot.2015.06.008 |
0.405 |
|
| 2014 |
Koul D, Yao J, Wan S, Yuan Y, Sulman E, Lang F, Yung WK, Colman H. Retraction: Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig 2-positive glioma tumor-initiating cells. Cancer Research. 74: 6731-2. PMID 25398854 DOI: 10.1158/0008-5472.Can-14-2966 |
0.377 |
|
| 2014 |
Verma J, Sulman EP, Jhingran A, Tucker SL, Rauch GM, Eifel PJ, Klopp AH. Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer. International Journal of Radiation Oncology, Biology, Physics. 88: 357-62. PMID 24411609 DOI: 10.1016/J.Ijrobp.2013.09.053 |
0.323 |
|
| 2014 |
Lichti CF, Liu H, Shavkunov AS, Mostovenko E, Sulman EP, Ezhilarasan R, Wang Q, Kroes RA, Moskal JC, Fenyö D, Oksuz BA, Conrad CA, Lang FF, Berven FS, Végvári A, et al. Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines. Journal of Proteome Research. 13: 191-9. PMID 24266786 DOI: 10.1021/Pr400786S |
0.385 |
|
| 2014 |
Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells. Stem Cells (Dayton, Ohio). 32: 301-12. PMID 24038660 DOI: 10.1002/Stem.1528 |
0.426 |
|
| 2014 |
Niola F, Zhao X, Singh D, Sullivan R, Castano A, Verrico A, Zoppoli P, Friedmann-Morvinski D, Sulman EP, Barrett L, Zhuang Y, Verma I, Benezra R, Aldape K, Iavarone A, et al. Erratum: Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis (The Journal of Clinical Investigation (2013) 123:1 (405-417) (DOI: 10.1172/JCI63811) Journal of Clinical Investigation. 124. DOI: 10.1172/Jci77927 |
0.303 |
|
| 2014 |
Hossain MB, Cortes-Santiago N, Fan X, Gabrusiewicz K, Gumin J, Sulman EP, Lang F, Sawaya R, Yung WKA, Fueyo J, Gomez-Manzano C. Abstract 3944: Caveolin-mediated Tie2 nuclear translocation results in enhanced NHEJ repair and glioma radioresistance Cancer Research. 74: 3944-3944. DOI: 10.1158/1538-7445.Am2014-3944 |
0.423 |
|
| 2014 |
Thomas C, Liang J, Piao Y, Nguyen N, Sulman E, Stephan C, Yung A, Groot JFd. Abstract 3744: High-throughput in vitro screening of glioma stem cell lines: Evaluation of over 350 tyrosine kinase inhibitors Cancer Research. 74: 3744-3744. DOI: 10.1158/1538-7445.Am2014-3744 |
0.353 |
|
| 2014 |
Nilsson CL, Vegvari A, Mostovenko E, Lichti CF, Fenyo D, Ruggles K, Sulman EP. SC-23 * THE ROLE OF SINGLE AMINO ACID POLYMORPHISMS IN GLIOMA STEM CELL PHENOTYPES Neuro-Oncology. 16: v202-v202. DOI: 10.1093/Neuonc/Nou275.23 |
0.433 |
|
| 2014 |
Singh S, Burrell K, Alamhabspour A, Agnihotri S, Vartanian A, Jalali S, Gumin J, Sulman E, Lang F, Zadeh G. Mr-04Dicer Regulates Glioma Stem Cell State Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou262.4 |
0.432 |
|
| 2014 |
Wang Q, Ezhilarasan R, Zheng S, Gumin J, Heffernan T, Draetta G, Lang F, Verhaak R, Sulman E. Ge-39Validation Of Glioma Sphere-Forming Cells As Models Of Glioblastoma And Identification Of Novel Drivers Of Tumorigenesis Through Comprehensive Genomic Characterization Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou256.38 |
0.46 |
|
| 2014 |
Wang Q, Ezhilarasan R, Zheng S, Gumin J, Heffernan T, Draetta G, Lang F, Verhaak R, Sulman E. Ge-38Identifying The Treatment-Resistant Mesenchymal Signature By Comparative Analyses Between Glioma Sphere-Forming Cells And Their Glioblastomas Of Origin Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou256.37 |
0.452 |
|
| 2014 |
Olar A, Wani K, Mansouri A, Zadeh G, Wilson C, DeMonte F, Fuller G, Jones D, Pfister S, Deimling Av, Sulman E, Aldape K. EG-09EPIGENETIC PROFILING REVEALS A CpG HYPERMETHYLATION PHENOTYPE (CIMP) ASSOCIATED WITH WORSE PROGRESSION-FREE SURVIVAL IN MENINGIOMA. Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou254.9 |
0.343 |
|
| 2014 |
Sulman EP, Wang Q, Ezhilarasan R, Goodman LD, Gumen J, Sun P, Aldape K, Yung WA, Heffernan T, Draetta GF, Lang FF. The Treatment-Resistant Mesenchymal Signature In Glioblastoma Derives From Tumor Cells Independent Of Stroma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou206.28 |
0.747 |
|
| 2014 |
Aldape K, Zadeh G, Sulman E. Molecular-Based Grading In Idh-Mutant Lower Grade Gliomas Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou206.17 |
0.373 |
|
| 2013 |
Bhat KP, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, Conroy S, Long L, Lelic N, Wang S, Gumin J, ... ... Sulman EP, et al. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell. 24: 331-46. PMID 23993863 DOI: 10.1016/J.Ccr.2013.08.001 |
0.718 |
|
| 2013 |
Piao Y, Liang J, Holmes L, Henry V, Sulman E, de Groot JF. Acquired resistance to anti-VEGF therapy in glioblastoma is associated with a mesenchymal transition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4392-403. PMID 23804423 DOI: 10.1158/1078-0432.Ccr-12-1557 |
0.417 |
|
| 2013 |
Zheng S, Fu J, Vegesna R, Mao Y, Heathcock LE, Torres-Garcia W, Ezhilarasan R, Wang S, McKenna A, Chin L, Brennan CW, Yung WK, Weinstein JN, Aldape KD, Sulman EP, et al. A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival. Genes & Development. 27: 1462-72. PMID 23796897 DOI: 10.1101/Gad.213686.113 |
0.388 |
|
| 2013 |
Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH. Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix. Gynecologic Oncology. 131: 645-9. PMID 23643871 DOI: 10.1016/J.Ygyno.2013.04.056 |
0.421 |
|
| 2013 |
Fu J, Koul D, Yao J, Wang S, Yuan Y, Colman H, Sulman EP, Lang FF, Yung WK. Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells. Cancer Research. 73: 3062-74. PMID 23492364 DOI: 10.1158/0008-5472.Can-12-2033 |
0.388 |
|
| 2013 |
Niola F, Zhao X, Singh D, Sullivan R, Castano A, Verrico A, Zoppoli P, Friedmann-Morvinski D, Sulman E, Barrett L, Zhuang Y, Verma I, Benezra R, Aldape K, Iavarone A, et al. Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis. The Journal of Clinical Investigation. 123: 405-17. PMID 23241957 DOI: 10.1172/Jci63811 |
0.472 |
|
| 2013 |
Holliday EB, Sulman EP. Tumor prognostic factors and the challenge of developing predictive factors. Current Oncology Reports. 15: 33-46. PMID 23224629 DOI: 10.1007/S11912-012-0283-3 |
0.417 |
|
| 2013 |
Likhacheva A, Pinnix CC, Parikh NR, Allen PK, McAleer MF, Chiu MS, Sulman EP, Mahajan A, Guha-Thakurta N, Prabhu SS, Cahill DP, Luo D, Shiu AS, Brown PD, Chang EL. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. International Journal of Radiation Oncology, Biology, Physics. 85: 656-61. PMID 22898384 DOI: 10.1016/J.Ijrobp.2012.05.047 |
0.357 |
|
| 2013 |
Sulman EP, Won M, Blumenthal DT, Vogelbaum MA, Colman H, Jenkins RB, Chakravarti A, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Dignam J, Atkins JN, Brachman D, Werner-Wasik M, et al. Molecular predictors of outcome and response to bevacizumab (BEV) based on analysis of RTOG 0825, a phase III trial comparing chemoradiation (CRT) with and without BEV in patients with newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology. 31. DOI: 10.1200/Jco.2013.31.15_Suppl.Lba2010 |
0.371 |
|
| 2013 |
Gilbert MR, Dignam J, Won M, Blumenthal DT, Vogelbaum MA, Aldape KD, Colman H, Chakravarti A, Jeraj R, Armstrong TS, Wefel JS, Brown PD, Jaeckle KA, Schiff D, Atkins JN, ... ... Sulman EP, et al. RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM). Journal of Clinical Oncology. 31: 1-1. DOI: 10.1200/Jco.2013.31.15_Suppl.1 |
0.337 |
|
| 2013 |
Fu J, Koul D, Zheng S, Singh V, Yao J, Zheng Y, Lu Z, Sulman EP, Lang FF, Yung AWK. Abstract 4909: Olig2 phosphorylation by CDK2 implicated in glioma proliferation. Cancer Research. 73: 4909-4909. DOI: 10.1158/1538-7445.Am2013-4909 |
0.376 |
|
| 2013 |
Saito N, Fu J, Wang S, Sulman EP, Lang FF, Yung WA, Koul D. Abstract 235: Oncogene addiction switch from NOTCH to PI3K/AKT requires simultaneous targeting of NOTCH and PI3K pathway inhibition in glioblastoma. Cancer Research. 73: 235-235. DOI: 10.1158/1538-7445.Am2013-235 |
0.373 |
|
| 2013 |
Cahill DP, George A, Gilbert MR, Chakravarti A, Stupp R, Hegi M, Brown P, Jaeckle KA, Corn B, Sulman EP, Souhami L, Werner-Wasik M, Anderson BM, Mehta M, Aldape KD. Abstract A110: EGFRvIII expression is associated with shorter progression-free and overall survival in glioblastoma patients treated with standard-of-care temozolomide and radiation: A report from the RTOG-0525 trial. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A110 |
0.408 |
|
| 2013 |
Sulman E, Ezhilarasan R, Goodman L, Wani K, Sharma D, Mody R, Cloughesy T, Lai A, DeMonte F, Aldape K. A Molecular Signature to Predict Meningioma Recurrence and Progression International Journal of Radiation Oncology*Biology*Physics. 87: S666. DOI: 10.1016/J.Ijrobp.2013.06.1765 |
0.656 |
|
| 2012 |
Likhacheva A, Pinnix CC, Parikh N, Allen PK, Guha-Thakurta N, McAleer M, Sulman EP, Mahajan A, Shiu A, Luo D, Chiu M, Brown PD, Prabhu SS, Chang EL. Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone. Journal of Neurosurgery. 117: 38-44. PMID 23205787 DOI: 10.3171/2012.3.Gks1289 |
0.376 |
|
| 2012 |
Debeb BG, Lacerda L, Xu W, Larson R, Solley T, Atkinson R, Sulman EP, Ueno NT, Krishnamurthy S, Reuben JM, Buchholz TA, Woodward WA. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling. Stem Cells (Dayton, Ohio). 30: 2366-77. PMID 22961641 DOI: 10.1002/Stem.1219 |
0.374 |
|
| 2012 |
Li J, Sulman E, Aldape K. Molecular biology of brain tumors. Handbook of Clinical Neurology. 104: 23-34. PMID 22230432 DOI: 10.1016/B978-0-444-52138-5.00002-5 |
0.39 |
|
| 2012 |
Pinnix CC, Fontanilla HP, Hayes-Jordan A, Subbiah V, Bilton SD, Chang EL, Grosshans DR, McAleer MF, Sulman EP, Woo SY, Anderson P, Green HL, Mahajan A. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery. International Journal of Radiation Oncology, Biology, Physics. 83: 317-26. PMID 22104361 DOI: 10.1016/J.Ijrobp.2011.06.1985 |
0.381 |
|
| 2012 |
Koay EJ, Bucheit AD, Jakob JA, Hyun ED, Settle SH, Brown PD, Davies MA, Sulman EP. Correlation of BRAF and NRAS mutation status with tumor characteristics and treatment outcomes in melanoma patients with brain metastasis. Journal of Clinical Oncology. 30: 8584-8584. DOI: 10.1200/Jco.2012.30.15_Suppl.8584 |
0.319 |
|
| 2012 |
Vaillant BD, Bhat K, Sulman EP, Balasubramaniyan V, Ezhilarasan R, Aldape KD, Colman H. The NF kappa B pathway as a key mediator of the glioblastoma mesenchymal subtype in glioblastoma stem cells and human tumors. Journal of Clinical Oncology. 30: 2002-2002. DOI: 10.1200/Jco.2012.30.15_Suppl.2002 |
0.462 |
|
| 2012 |
Chakravarti A, Wang M, Aldape KD, Sulman EP, Bredel M, Magliocco AM, Klimowicz AC, Hegi M, Stupp R, Gilbert MR, Curran WJ, Werner-Wasik M, Mahajan A, Schultz CJ, Mehta MP. A revised RTOG recursive partitioning analysis (RPA) model for glioblastoma based upon multiplatform biomarker profiles. Journal of Clinical Oncology. 30: 2001-2001. DOI: 10.1200/Jco.2012.30.15_Suppl.2001 |
0.354 |
|
| 2012 |
Bhat KPL, Vaillant B, Balasubramainyan V, Ezhilarasan R, Hollingsworth F, James J, Wani K, Goodman L, Sulman E, Colman H, Aldape K. Abstract 3314: Phenotypic plasticity in glioma stem cells mediated by NFκB signaling Cancer Research. 72: 3314-3314. DOI: 10.1158/1538-7445.Am2012-3314 |
0.727 |
|
| 2012 |
Kozono D, Nitta M, Sampetrean O, Kimberly N, Kushwaha D, Merzon D, Ligon K, Zhu S, Zhu K, Kim TH, Kwon C, Becher O, Saya H, Chen CC, Donovan LK, ... ... Sulman EP, et al. LAB-STEM CELLS Neuro-Oncology. 14: vi142-vi152. DOI: 10.1093/Neuonc/Nos239 |
0.306 |
|
| 2012 |
Proescholdt MA, Merrill MJ, Stoerr E, Lohmeier A, Brawanski A, Sim H, Hu B, Pineda CA, Yoon S, Viapiano MS, Rajappa P, Cobb WS, Huang Y, Lyden DC, Bromberg J, ... ... Sulman E, et al. LAB-ANGIOGENESIS AND INVASION Neuro-Oncology. 14: vi1-vi6. DOI: 10.1093/Neuonc/Nos219 |
0.319 |
|
| 2012 |
Sulman EP, Wang M, Cahill DP, Won M, Hegi M, Mehta M, Gilbert MR, Aldape KD. 287 Combining Molecular And Clinical Factors To Predict Survival Of Patients With Glioblastoma And Validation Using Rtog 0525 Radiotherapy and Oncology. 102. DOI: 10.1016/S0167-8140(12)70250-5 |
0.313 |
|
| 2011 |
Vaillant BD, Bhat K, Sulman EP, Balasubramaniyan V, Wang S, Aldape KD, Colman H. CD44 as a prognostic and predictive marker for GBM. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2049. PMID 28023811 DOI: 10.1200/Jco.2011.29.15_Suppl.2049 |
0.44 |
|
| 2011 |
Aldape KD, Wang M, Sulman EP, Hegi M, Colman H, Jones G, Chakravarti A, Mehta MP, Andrews DW, Long L, Diefes K, Heathcock L, Jenkins R, Schultz CJ, Gilbert MR, et al. RTOG 0525: Molecular correlates from a randomized phase III trial of newly diagnosed glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: LBA2000. PMID 27937153 DOI: 10.1200/Jco.2011.29.18_Suppl.Lba2000 |
0.319 |
|
| 2011 |
Bhat KP, Salazar KL, Balasubramaniyan V, Wani K, Heathcock L, Hollingsworth F, James JD, Gumin J, Diefes KL, Kim SH, Turski A, Azodi Y, Yang Y, Doucette T, Colman H, ... Sulman EP, et al. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes & Development. 25: 2594-609. PMID 22190458 DOI: 10.1101/Gad.176800.111 |
0.359 |
|
| 2011 |
Miller CA, Settle SH, Sulman EP, Aldape KD, Milosavljevic A. Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors. Bmc Medical Genomics. 4: 34. PMID 21489305 DOI: 10.1186/1755-8794-4-34 |
0.357 |
|
| 2011 |
de Groot JF, Sulman EP, Aldape KD. Multigene sets for clinical application in glioma. Journal of the National Comprehensive Cancer Network : Jnccn. 9: 449-56; quiz 457. PMID 21464148 DOI: 10.6004/Jnccn.2011.0040 |
0.423 |
|
| 2011 |
Bonato V, Baladandayuthapani V, Broom BM, Sulman EP, Aldape KD, Do KA. Bayesian ensemble methods for survival prediction in gene expression data. Bioinformatics (Oxford, England). 27: 359-67. PMID 21148161 DOI: 10.1093/Bioinformatics/Btq660 |
0.301 |
|
| 2011 |
Sulman EP, Aldape K. The use of global profiling in biomarker development for gliomas. Brain Pathology (Zurich, Switzerland). 21: 88-95. PMID 21129062 DOI: 10.1111/J.1750-3639.2010.00456.X |
0.438 |
|
| 2011 |
Settle SH, Sulman EP. Tumor profiling: development of prognostic and predictive factors to guide brain tumor treatment. Current Oncology Reports. 13: 26-36. PMID 21082294 DOI: 10.1007/S11912-010-0138-8 |
0.421 |
|
| 2011 |
Goodman LD, Bhat K, Gumin J, Ezhilarasan R, Gao F, Love P, Colman H, Lang F, Aldape K, Sulman E. Abstract 3313: A proliferating population of glioma stem-like cells as characterized by expression of the cell surface glycoprotein CD58 Cancer Research. 71: 3313-3313. DOI: 10.1158/1538-7445.Am2011-3313 |
0.722 |
|
| 2011 |
Ezhilarasan R, Love PN, Goodman LD, Aldape KD, Sulman EP. Abstract 2467: Podoplanin expressing cancer stem cells show increased resistance to DNA damage induced by ionizing radiation Cancer Research. 71: 2467-2467. DOI: 10.1158/1538-7445.Am2011-2467 |
0.761 |
|
| 2010 |
Sulman EP, Guerrero M, Mikkelsen T, Bonato V, Phillips HS, Berger MS, Collins P, Broom B, Do K, Aldape KD. A mesenchymal/stem cell predictor of survival of patients with malignant gliomas. Journal of Clinical Oncology. 28: 2049-2049. DOI: 10.1200/Jco.2010.28.15_Suppl.2049 |
0.427 |
|
| 2010 |
Ezhilarasan R, Goodman LD, Love PN, Aldape KD, Sulman EP. Abstract 5157: Functional and regulatory role of src kinase in podoplanin expressing glioma cancer stem cells Cancer Research. 70: 5157-5157. DOI: 10.1158/1538-7445.Am10-5157 |
0.766 |
|
| 2010 |
Love PN, Ezhilarasan R, Goodman LD, Aldape KD, Sulman EP. Abstract 5147: Trancriptional activation of the glioma stem cell marker podoplanin by the homeobox transcription factor prox1 Cancer Research. 70: 5147-5147. DOI: 10.1158/1538-7445.Am10-5147 |
0.753 |
|
| 2010 |
Goodman LD, Gao F, Gumin J, Villareal D, Ezhilarasan R, Love P, Colman H, Lang FF, Aldape KD, Sulman EP. Abstract 4305: Refinement of the glioma cancer stem cell marker profile Cancer Research. 70: 4305-4305. DOI: 10.1158/1538-7445.Am10-4305 |
0.739 |
|
| 2010 |
Hyun ED, Cahill DP, McAleer MF, George A, Shiu AS, Mahajan A, Chang EL, Sulman EP. Outcome of Patients Treated with Gamma Knife Stereotactic Radiosurgery for Brain Metastases from Melanoma and Association of BRAF Oncogene Mutation Status with Survival International Journal of Radiation Oncology Biology Physics. 78. DOI: 10.1016/J.Ijrobp.2010.07.646 |
0.313 |
|
| 2010 |
Mahajan A, Anderson P, McAleer M, Sulman E, Pinnix C, Woo S, Herzog C, Hayes-Jordan A. Multidisciplinary Management with Whole Abdominal IMRT of Desmoplastic Small Round Cell Tumor International Journal of Radiation Oncology*Biology*Physics. 78: S593. DOI: 10.1016/J.Ijrobp.2010.07.1382 |
0.35 |
|
| 2009 |
Sulman EP, Guerrero M, Aldape K. Beyond grade: molecular pathology of malignant gliomas. Seminars in Radiation Oncology. 19: 142-9. PMID 19464628 DOI: 10.1016/J.Semradonc.2009.02.001 |
0.452 |
|
| 2009 |
Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiation Oncology (London, England). 4: 5. PMID 19183471 DOI: 10.1186/1748-717X-4-5 |
0.313 |
|
| 2009 |
Sulman EP, Eifel PJ, Jhingran A, Aldape KD, Deavers MT, Klopp AH. Podoplanin Expression is Prognostic for Survival of Patients with Squamous Cell Carcinoma of the Cervix Treated with Definitive Radiation Therapy International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.850 |
0.348 |
|
| 2009 |
Ezhilarasan R, Love PN, Goodman LD, Aldape KD, Sulman EP. Expression of c-met in Human Glioblastoma Does Not Correlate with Patient Survival or Clinical Radiation Response International Journal of Radiation Oncology Biology Physics. 75. DOI: 10.1016/J.Ijrobp.2009.07.581 |
0.698 |
|
| 2008 |
Sulman EP, Aldape K, Colman H. Brain tumor stem cells. Current Problems in Cancer. 32: 124-142. PMID 18501775 DOI: 10.1016/J.Currproblcancer.2008.02.004 |
0.391 |
|
| 2008 |
Rivera AL, Pelloski CE, Sulman E, Aldape K. Prognostic and predictive markers in glioma and other neuroepithelial tumors. Current Problems in Cancer. 32: 97-123. PMID 18501774 DOI: 10.1016/J.Currproblcancer.2008.02.003 |
0.39 |
|
| 2008 |
Woodward WA, Sulman EP. Cancer stem cells: markers or biomarkers? Cancer Metastasis Reviews. 27: 459-70. PMID 18437295 DOI: 10.1007/S10555-008-9130-2 |
0.333 |
|
| 2008 |
Lang FF, Gumin J, Amano T, Hata N, Heimberger AB, Marini F, Andreeff M, Aldape KD, Sulman E, Colman H. Tumor-derived mesenchymal stem cells in human gliomas: Isolation and biological properties Journal of Clinical Oncology. 26: 2001-2001. DOI: 10.1200/Jco.2008.26.15_Suppl.2001 |
0.418 |
|
| 2008 |
Sulman EP, Pelloski CE, Aldape KD. Analysis of Patients Receiving Histone Deacetylase Inhibiting Antiepileptic Agents during Radiation Treatment for Glioblastoma International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.696 |
0.331 |
|
| Show low-probability matches. |